Nonorgan-specific autoantibodies in individuals infected with type 1 human immunodeficiency virus. 1991

A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
Department of Internal Medicine, Brest University Medical School, France.

Fifty-six human immunodeficiency virus-1-positive asymptomatic carriers were tested for the presence of a variety of nonorgan-specific autoantibodies. Antinuclear antibodies were detected in 34 sera, of which 27 were directed to the mitotic spindle apparatus and all were of the IgG isotype. Anti-Golgi complex, anti-centriole, and anti-vimentin antibodies were also present in 20.4, and 4 sera, respectively. Ten patients had less than 500 CD4-carrying T lymphocytes per cubic millimeter. Nine of them had more than one autoantibody. No correlation could be demonstrated between the number of autoantibodies and the level of serum immunoglobulins.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
January 1990, Disease markers,
A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
May 1989, Proceedings of the National Academy of Sciences of the United States of America,
A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
October 1990, The Journal of experimental medicine,
A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
August 1995, The Journal of clinical investigation,
A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
August 1999, Journal of virology,
A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
March 2009, Journal of virology,
A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
March 2017, Medicine,
A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
August 1999, The Journal of infectious diseases,
A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
January 1989, Journal of acquired immune deficiency syndromes,
A Gentric, and M Blaschek, and C Julien, and J Jouquan, and Y Pennec, and J M Berthelot, and D Mottier, and R Casburn-Budd, and P Youinou
January 2007, Microbiology and immunology,
Copied contents to your clipboard!